A new imaging modality could make it possible to navigate tissue specimens with the speed and detail of Google Maps

Researchers hope to create a device that can draw, process and test blood in just 30 minutes

New recommendations on improving the diagnostic process focus on errors, communication, and putting the patient at the center of healthcare

Gene expression panel could help breast cancer patients with a low risk of recurrence avoid unnecessary chemotherapy

Liquid crystal displays are ubiquitous, but could the technology be used to detect early-stage amyloid fibril formation?

A genetic test for prostate cancer risk could be used in screening, and improve the diagnostic value of PSA

Could a technique that detects all known human viruses take the guesswork out of ordering lab tests?

Keith Miller is Director and co-founder of CADQAS (Cancer Diagnostic Quality Assurance Services), a not-for-profit community interest company hosted by Poundbury Cancer Institute (PCI).

Christopher Hudson is Director of Tissue Diagnostics UK and Ireland at Roche, the multinational life sciences company that supports the Poundbury Cancer Institute through funding and research collaboration.

At the Poundbury Cancer Center, pathology, business and quality assurance are uniting to create a cutting-edge home for companion diagnostics.